• mail us help@24marketresearch.com
  • Int'l (+1)-646-781-7170
  • UK(Toll free) +44-800-088-5734

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Epigenetic Market Size, Status and Forecast 2018-2025

Global Epigenetic Market Size, Status and Forecast 2018-2025

  • Category:ICT & Media
  • Published on : 29 August 2018
  • Pages :91
  • Formats:
  • Report Code:24MRES-3055874
Click for best price

Best Price: $3120

This report focuses on the global Epigenetic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epigenetic development in United States, Europe and China.

Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
United States will continue to dominate the Epigenetic market for due to high availability of funding for research.
The growing government initiatives and increasing number of Biotechnology and Biopharmaceutical companies in APAC is also driving the market of epigenetic in APAC.
In 2017, the global Epigenetic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis

Market analysis by product type
DNA modifying Enzymes
RNA modifying Enzymes
Protein Modifying Enzymes

Market analysis by market
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Contract Research Organizations

Market analysis by Region
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Epigenetic status, future forecast, growth opportunity, key market and key players.
To present the Epigenetic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Epigenetic are as follows:
History Year: 2017-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENTS

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Epigenetic Market Size Growth Rate by Type (2018-2025)
1.4.2 DNA modifying Enzymes
1.4.3 RNA modifying Enzymes
1.4.4 Protein Modifying Enzymes
1.5 Market by Application
1.5.1 Global Epigenetic Market Share by Application (2017-2025)
1.5.2 Academic Research Institutes
1.5.3 Biotechnology Companies
1.5.4 Biopharmaceutical Companies
1.5.5 Diagnostic Companies
1.5.6 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Epigenetic Market Size
2.2 Epigenetic Growth Trends by Regions
2.2.1 Epigenetic Market Size by Regions (2017-2025)
2.2.2 Epigenetic Market Share by Regions (2017-2025)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Epigenetic Revenue by Manufacturers (2017-2018)
3.2 Epigenetic Key Players Head office and Area Served
3.3 Key Players Epigenetic Product/Solution/Service
3.4 Date of Enter into Epigenetic Market
3.5 Key Players Epigenetic Funding/Investment Analysis
3.6 Global Key Players Epigenetic Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Epigenetic Market Size by Type (2017-2025)
4.2 Global Epigenetic Market Size by Application (2017-2025)

5 United States
5.1 United States Epigenetic Market Size (2017-2025)
5.2 Epigenetic Key Players in United States
5.3 United States Epigenetic Market Size by Type
5.4 United States Epigenetic Market Size by Application

6 Europe
6.1 Europe Epigenetic Market Size (2017-2025)
6.2 Epigenetic Key Players in Europe
6.3 Europe Epigenetic Market Size by Type
6.4 Europe Epigenetic Market Size by Application

7 China
7.1 China Epigenetic Market Size (2017-2025)
7.2 Epigenetic Key Players in China
7.3 China Epigenetic Market Size by Type
7.4 China Epigenetic Market Size by Application

8 Rest of World
8.1 Japan
8.1.1 Japan Epigenetic Market Analysis
8.1.2 Key Players in
8.2 Southeast Asia
8.2.1 Southeast Asia Epigenetic Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Epigenetic Market Analysis
8.3.2 Key Players in India

9 International Players Profiles
9.1 Illumina
9.1.1 Illumina Company Details
9.1.2 Company Description and Business Overview
9.1.3 Epigenetic Introduction
9.1.4 Illumina Revenue in Epigenetic Business (2017-2018)
9.1.5 Illumina Recent Development
9.2 Qiagen
9.2.1 Qiagen Company Details
9.2.2 Company Description and Business Overview
9.2.3 Epigenetic Introduction
9.2.4 Qiagen Revenue in Epigenetic Business (2017-2018)
9.2.5 Qiagen Recent Development
9.3 Abcam
9.3.1 Abcam Company Details
9.3.2 Company Description and Business Overview
9.3.3 Epigenetic Introduction
9.3.4 Abcam Revenue in Epigenetic Business (2017-2018)
9.3.5 Abcam Recent Development
9.4 Merck & Co
9.4.1 Merck & Co Company Details
9.4.2 Company Description and Business Overview
9.4.3 Epigenetic Introduction
9.4.4 Merck & Co Revenue in Epigenetic Business (2017-2018)
9.4.5 Merck & Co Recent Development
9.5 Sigma-Aldrich
9.5.1 Sigma-Aldrich Company Details
9.5.2 Company Description and Business Overview
9.5.3 Epigenetic Introduction
9.5.4 Sigma-Aldrich Revenue in Epigenetic Business (2017-2018)
9.5.5 Sigma-Aldrich Recent Development
9.6 New England Biolabs
9.6.1 New England Biolabs Company Details
9.6.2 Company Description and Business Overview
9.6.3 Epigenetic Introduction
9.6.4 New England Biolabs Revenue in Epigenetic Business (2017-2018)
9.6.5 New England Biolabs Recent Development
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Company Details
9.7.2 Company Description and Business Overview
9.7.3 Epigenetic Introduction
9.7.4 Thermo Fisher Scientific Revenue in Epigenetic Business (2017-2018)
9.7.5 Thermo Fisher Scientific Recent Development
9.8 Diagenode
9.8.1 Diagenode Company Details
9.8.2 Company Description and Business Overview
9.8.3 Epigenetic Introduction
9.8.4 Diagenode Revenue in Epigenetic Business (2017-2018)
9.8.5 Diagenode Recent Development
9.9 Active Motif
9.9.1 Active Motif Company Details
9.9.2 Company Description and Business Overview
9.9.3 Epigenetic Introduction
9.9.4 Active Motif Revenue in Epigenetic Business (2017-2018)
9.9.5 Active Motif Recent Development
9.10 Roche Diagnostics
9.10.1 Roche Diagnostics Company Details
9.10.2 Company Description and Business Overview
9.10.3 Epigenetic Introduction
9.10.4 Roche Diagnostics Revenue in Epigenetic Business (2017-2018)
9.10.5 Roche Diagnostics Recent Development
9.11 Eisai
9.12 Novartis

10 Market Dynamics
10.1 Drivers
10.2 Opportunities
10.3 Challenges
10.4 Market Ecosystem
10.5 Market Value Chain Analysis

11 Key Findings in This Report

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details

LIST OF TABLES & FIGURES

List of Tables and Figures

Table Epigenetic Key Market Segments
Table Key Players Epigenetic Covered
Table Global Epigenetic Market Size Growth Rate by Type 2018-2025 (Million US$)
Figure Global Epigenetic Market Size Market Share by Type 2018-2025
Figure DNA modifying Enzymes Figures
Table Key Players of DNA modifying Enzymes
Figure RNA modifying Enzymes Figures
Table Key Players of RNA modifying Enzymes
Figure Protein Modifying Enzymes Figures
Table Key Players of Protein Modifying Enzymes
Table Global Epigenetic Market Size Growth by Application 2018-2025 (Million US$)
Figure Academic Research Institutes Case Studies
Figure Biotechnology Companies Case Studies
Figure Biopharmaceutical Companies Case Studies
Figure Diagnostic Companies Case Studies
Figure Contract Research Organizations Case Studies
Figure Epigenetic Report Years Considered
Table Global Epigenetic Market Size 2017-2025 (Million US$)
Figure Global Epigenetic Market Size and Growth Rate 2017-2025 (Million US$)
Table Global Epigenetic Market Size by Regions 2018-2025 (Million US$)
Table Global Epigenetic Market Size by Regions 2017-2025 (Million US$)
Table Global Epigenetic Market Share by Regions 2013-2018
Figure Global Epigenetic Market Share by Regions 2017-2025
Figure Global Epigenetic Market Share by Regions 2018-2025
Table Market Top Trends
Table Global Epigenetic Revenue by Manufacturers (2017-2018) (Million US$)
Table Global Epigenetic Market Share by Manufacturers (2017-2018)
Figure Global Epigenetic Market Share by Manufacturers in 2018
Table Global Key Players Epigenetic Funding/Investment Analysis (Million US$)
Table Global Key Players Epigenetic Valuation & Market Capitalization (Million US$)
Table Mergers & Acquisitions, Expansion Plans
Table Global Epigenetic Market Size by Type (2017-2025) (Million US$)
Table Global Epigenetic Market Share by Type (2017-2025)
Figure Global Epigenetic Market Size Share by Type (2017-2025)
Table Global Epigenetic Market Size by Application (2017-2025) (Million US$)
Table Global Epigenetic Market Size Share by Application (2017-2025)
Figure Global Epigenetic Market Size Market Share by Application (2017-2025)
Figure Global Epigenetic Revenue Market Share by Application in 2017
Figure United States Epigenetic Market Size 2017-2025 (Million US$)
Table United States Key Players Epigenetic Revenue (2017-2018) (Million US$)
Table United States Key Players Epigenetic Market Share (2017-2018)
Table United States Epigenetic Market Size by Type (2017-2025) (Million US$)
Table United States Epigenetic Market Share by Type (2017-2025)
Table United States Epigenetic Market Size by Application (2017-2025) (Million US$)
Table United States Epigenetic Market Share by Application (2017-2025)
Figure Europe Epigenetic Market Size 2017-2025 (Million US$)
Table Europe Key Players Epigenetic Revenue (2017-2018) (Million US$)
Table Europe Key Players Epigenetic Market Share (2017-2018)
Table Europe Epigenetic Market Size by Type (2017-2025) (Million US$)
Table Europe Epigenetic Market Share by Type (2017-2025)
Table Europe Epigenetic Market Size by Application (2017-2025) (Million US$)
Table Europe Epigenetic Market Share by Application (2017-2025)
Figure China Epigenetic Market Size 2017-2025 (Million US$)
Table China Key Players Epigenetic Revenue (2017-2018) (Million US$)
Table China Key Players Epigenetic Market Share (2017-2018)
Table China Epigenetic Market Size by Type (2017-2025) (Million US$)
Table China Epigenetic Market Share by Type (2017-2025)
Table China Epigenetic Market Size by Application (2017-2025) (Million US$)
Table China Epigenetic Market Share by Application (2017-2025)
Figure Market Size in Japan Epigenetic 2017-2025 (Million US$)
Figure Market Size in Southeast Asia Epigenetic 2017-2025 (Million US$)
Figure Market Size in India Epigenetic 2017-2025 (Million US$)
Table Illumina Company Details
Table Illumina Revenue in Epigenetic Business in 2017 and 2018
Table Illumina Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Epigenetic Business in 2017 and 2018
Table Qiagen Recent Development
Table Abcam Company Details
Table Abcam Revenue in Epigenetic Business in 2017 and 2018
Table Abcam Recent Development
Table Merck & Co Company Details
Table Merck & Co Revenue in Epigenetic Business in 2017 and 2018
Table Merck & Co Recent Development
Table Sigma-Aldrich Company Details
Table Sigma-Aldrich Revenue in Epigenetic Business in 2017 and 2018
Table Sigma-Aldrich Recent Development
Table New England Biolabs Company Details
Table New England Biolabs Revenue in Epigenetic Business in 2017 and 2018
Table New England Biolabs Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Epigenetic Business in 2017 and 2018
Table Thermo Fisher Scientific Recent Development
Table Diagenode Company Details
Table Diagenode Revenue in Epigenetic Business in 2017 and 2018
Table Diagenode Recent Development
Table Active Motif Company Details
Table Active Motif Revenue in Epigenetic Business in 2017 and 2018
Table Active Motif Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Epigenetic Business in 2017 and 2018
Table Roche Diagnostics Recent Development
Table Eisai Company Details
Table Novartis Company Details
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SELECT A FORMAT

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount
  BENCHMARKS  
Loading Time: Base Classes  0.0103
Controller Execution Time ( Reports Controller / Report Details )  7.0491
Total Execution Time  7.0605
  GET DATA  
No GET data exists
  MEMORY USAGE  
1,178,400 bytes
  POST DATA  
No POST data exists
  URI STRING  
ict-and-media/3055874/global-epigenetic-2018-2025-784
  CLASS/METHOD  
Reports_controller/report_details
  DATABASE:  chemical_common24 (Reports_controller:$db)   QUERIES: 12 (7.0259 seconds)  (Hide)
0.0001   SELECT GET_LOCK('4e8c09c02849ee1cb1fc8463902c5a83'300) AS ci_session_lock 
0.0215   SELECT `data`
FROM `24mresearch_ci_sessions`
WHERE `id` = 'b9aaf5aa4bfa1bedf6af581a6c457c301444f354' 
0.1418   SELECT `24_report`.*, `24_sub_cat_1`.`sc1_name`, `24_sub_cat_1`.`sc1_url`, `24_sub_cat_1`.`sc1_status`, `24_publisher`.`publisher_name`, `24_report_metadata`.*
FROM `24_report`
LEFT JOIN `24_sub_cat_1ON `24_sub_cat_1`.`sc1_id` = `24_report`.`rep_sub_cat_1_id`
LEFT JOIN `24_publisherON `24_publisher`.`publisher_id` = `24_report`.`publisher_id`
LEFT JOIN `24_report_metadataON `24_report_metadata`.`meta_rep_id` = `24_report`.`rep_id`
WHERE `rep_status` = 'Y'
AND `rep_archive_status` = 'N'
AND `rep_date` > '2017-03-31'
AND `24_report`.`rep_id` = '3055874' 
0.0004   SELECT `sc1_id`, `sc1_url`, `sc1_name`
FROM `24_sub_cat_1`
WHERE `sc1_status` = 'Y'
ORDER BY `sc1_idAS
0.0002   SELECT *
FROM `24_report_license`
WHERE `li_rep_id` = '3055874'
AND `li_pub_id` = '1' 
6.8614   SELECT `24_report`.`rep_title`, `24_report`.`rep_id`, `24_report`.`rep_url`, `24_report`.`rep_date`, `24_sub_cat_1`.`sc1_url`, `24_sub_cat_1`.`sc1_name`
FROM `24_report`
LEFT JOIN `24_sub_cat_1ON `24_report`.`rep_sub_cat_1_id`=`24_sub_cat_1`.`sc1_id`
WHERE `rep_status` = 'Y'
AND `rep_archive_status` = 'N'
AND `rep_date` > '2017-03-31'
AND  `rep_titleLIKE '%epigenetic%' ESCAPE '!'
 
LIMIT 4 
0.0002   SELECT FROM 24_report_currency WHERE cur_symbol 'GBP' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'EUR' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'JPY' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'GBP' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'EUR' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'JPY' 
  HTTP HEADERS  (Show)
  SESSION DATA  (Show)
  CONFIG VARIABLES  (Show)